After more than 70 years of partnership, pharmaceutical firms Merck of Germany and Bracco of Italy may be ending their alliance. The two companies are discussing whether Merck will sell its sizable stake in Bracco, according to a company statement. Merck
After more than 70 years of partnership, pharmaceutical firms Merck of Germany and Bracco of Italy may be ending their alliance. The two companies are discussing whether Merck will sell its sizable stake in Bracco, according to a company statement. Merck supplies Bracco with key chemicals used in the production of x-ray contrast media, and is believed to hold as much as 50% of the family-owned company.
The companies are debating whether to split the international imaging business from the Italian-based pharmaceutical ethicals, over-the-counter, and laboratory diagnostic products. The companies believe the split would make the businesses more efficient and allow them to better compete on the market.
Bracco and other contrast companies have struggled to weather declining profit margins caused by the erosion in prices for x-ray contrast media. Last year, nearly every major publicly traded contrast media supplier reported that ongoing pricing pressure in the U.S. x-ray market had decreased their profitability (SCAN 6/10/98).
MRI-Based AI Radiomics Model Offers 'Robust' Prediction of Perineural Invasion in Prostate Cancer
July 26th 2024A model that combines MRI-based deep learning radiomics and clinical factors demonstrated an 84.8 percent ROC AUC and a 92.6 percent precision-recall AUC for predicting perineural invasion in prostate cancer cases.
Breast MRI Study Examines Common Factors with False Negatives and False Positives
July 24th 2024The absence of ipsilateral breast hypervascularity is three times more likely to be associated with false-negative findings on breast MRI and non-mass enhancement lesions have a 4.5-fold likelihood of being linked to false-positive results, according to new research.
Can Polyenergetic Reconstruction Help Resolve Streak Artifacts in Photon Counting CT?
July 22nd 2024New research looking at photon-counting computed tomography (PCCT) demonstrated significantly reduced variation and tracheal air density attenuation with polyenergetic reconstruction in contrast to monoenergetic reconstruction on chest CT.